(Q67898809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826957%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Disturbances of essential fatty acid- and prostaglandin E-mediated immunoregulation in atopy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826957%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

3 December 2022

author name string

B. C. Melnik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826957

3 December 2022

G. Plewig

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826957

3 December 2022

T. Tschung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826957

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1826957

3 December 2022

publication date

1 February 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826957%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:095232789190079K?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

https://api.elsevier.com/content/article/PII:095232789190079K?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Prostaglandins, Leukotrienes and Essential Fatty Acids

3 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826957%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826957%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826957%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

125-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826957%20AND%20SRC:MED&resulttype=core&format=json

T cell responses in allergic rhinitis, asthma and atopic dermatitis

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome

3 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

IgE production in vitro by human blood mononuclear cells: a comparison between atopic and nonatopic subjects

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Abnormal regulation of in vitro IgE synthesis by T cells obtained from patients with atopic dermatitis

3 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Effect of Cyclic AMP-Elevating Agents on Human Spontaneous IgE Synthesis in vitro

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Altered arachidonic acid content in polymorphonuclear and mononuclear cells from patients with allergic rhinitis and/or asthma

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Essential fatty acids in serum lecithin of children with atopic dermatitis and in umbilical cord serum of infants with high or low IgE levels

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Breast milk fatty acids in mothers of children with atopic eczema

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

IgE screening in 1701 newborn infants and the development of atopic disease during infancy

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

High-affinity binding sites for prostaglandin E on human lymphocytes

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Lymphocyte hormone receptors

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes

3 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity

3 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2)

3 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Reduced prostaglandin E2 (PGE2) receptors on atopic T lymphocytes.

3 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Regulation of the immune response by prostaglandins

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Control of lymphokine secretion by prostaglandins

3 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Reduced production of histamine-induced suppressor factor (HSF) by atopic mononuclear cells and decreased prostaglandin E2 output by HSF-stimulated atopic monocytes

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

In situ immunophenotyping of antigen presenting cells and T cell subsets in atopic dermatitis

3 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis

3 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations

3 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Inability of skin enzyme preparations to biosynthesize arachidonic acid from linoleic acid.

3 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Oral evening-primrose-seed oil improves atopic eczema

3 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response

3 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Gammalinolenic acid-enriched diet alters cutaneous eicosanoids

3 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Oxidative metabolism of dihomogammalinolenic acid by guinea pig epidermis: evidence of generation of anti-inflammatory products

3 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Prostaglandin inhibition of T-cell proliferation is mediated at two levels

3 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T-cell subpopulations

3 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production

3 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells

3 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

E-series prostaglandins are potent growth inhibitors for some B lymphomas.

3 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Role and function of antigen nonspecific suppressor factors

3 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Cyclic AMP as the second messenger for prostaglandin E in modulating suppressor cell-activation by natural suppressor/cytotoxic cells

3 December 2022

41

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23).

3 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Dysregulation of arachidonic acid release and metabolism by atopic mononuclear cells

3 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Regulation of theta-antigen expression by agents altering cyclic AMP level and by thymic factor

3 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Anti-PGE antibodies inhibit in vivo development of cell-mediated immunity

3 December 2022

46

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Lymphocyte differentiation from precursor cells in vitro

3 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Differences in Cyclic AMP Changes after Stimulation by Prostaglandins and Isoproterenol in Lymphocyte Subpopulations

3 December 2022

48

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Prostaglandin secretion by human thymic epithelium: in vitro effects of steroids

3 December 2022

49

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Prostaglandin production by phagocytic cells of the mouse thymic reticulum in culture and its modulation by indomethacin and corticosteroids

3 December 2022

50

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Is thymosin action mediated by prostaglandin release?

3 December 2022

51

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Relation between arachidonic acid metabolism and development of thymocytes in fetal thymic organ cultures

3 December 2022

52

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Prolonged breast-feeding as prophylaxis for atopic disease

3 December 2022

53

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Elevated serum immunoglobulin E in T cell-deficient infants fed cow's milk

3 December 2022

54

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Evidence for the Carter effect in atopy

3 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Does breast feeding help protect against atopic disease? Biology, methodology, and a golden jubilee of controversy

3 December 2022

56

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

Atopy: a prostaglandin E precursor- and receptor-dependent defect in T-cell maturation and function?

3 December 2022

57

1 reference

https://api.crossref.org/works/10.1016/0952-3278(91)90079-K

3 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826957%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference